Zeteo Tech and BioFlyte reunite as Spectara

Six years after spinning out its commercial arm, Zeteo Tech has recombined with BioFlyte under a single new identity: Spectara. The reunited company focuses on two applications of its detection technology — biosecurity and individual infection identification.

NIH grant funds non-invasive pathogen screening research

A competitive grant from the National Institutes of Health supports early development of non-invasive approaches to population-scale pathogen screening.

Tibbetts Award, U.S. Small Business Administration

Recognized under the SBA's SBIR/STTR programs for outstanding small-business innovation in biological detection technology.